SXMDF News 14.4300 Sirtex Medical Ltd (SXMDF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sirtex Medical Ltd (SXMDF) 14.4300 $SXMDF

Sirtex Medical Inc. Reports 25.8 Percent Dose Sales Growth of SIR-Spheres(R) microspheres in Third Quarter
Business Wire - Fri Apr 04, 9:02AM CDT
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, recently announced that during the quarter ending March 2014, dose sales of SIR-Spheres(R) microspheres grew 25.8 percent in the Americas region compared to the previous corresponding period. Globally, Sirtex has now achieved 39 consecutive quarters of does sales growth.

Sirtex and Guerbet to Collaborate on Clinical Studies in Primary and Secondary Liver Cancer
CNW Group - Mon Mar 24, 10:42AM CDT
Sirtex Medical Limited (ASX:SRX) and Guerbet S.A. (EPA:GBT) announce today that the two companies will enter into a major clinical studies collaboration in primary and secondary (metastatic) liver cancer. The objective of the collaboration is to examine how Sirtex's SIR-Spheres(®) microspheres and Guerbet's Lipiodol(®) may be combined or sequenced optimally - and further developed - to address the significant unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, metastatic neuroendocrine tumours, and a range of other primary and secondary liver cancers.

Sirtex and Guerbet Announce Collaboration On Clinical Studies in Liver Cancer
PR Newswire - Mon Mar 24, 10:25AM CDT
Sirtex Medical Limited (ASX: SRX) and Guerbet S.A. (GBT.PA) are pleased to announce today that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer. The objective of the collaboration is to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers*.

Sirtex Medical Inc. Reports 23.7 Percent Dose Sales Growth of SIR-Spheres(R) microspheres in Second Quarter
Business Wire - Mon Jan 13, 9:00AM CST
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, recently announced that second quarter dose sales of SIR-Spheres(R) microspheres grew 23.7 percent in the Americas region compared to the previous corresponding period for the quarter ending December 31, 2013.

Liver Cancer Global Clinical Trials Review, H2, 2013 Features Players such as Pfizer Inc., Eli Lilly and Company and Novartis AG
M2 - Fri Dec 13, 5:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/btqlz5/liver_cancer) has announced the addition of the "Liver Cancer Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Cancer. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Companies Mentioned: -AstraZeneca PLC -Bayer AG -Bristol-Myers Squibb Company -Eastern Hepatobiliary Surgery Hospital -Eli Lilly and Company -F. Hoffmann-La Roche Ltd. -FUDAN University -Massachusetts General Hospital -Memorial Sloan Kettering Cancer Center -National Cancer Institute -National Taiwan University Hospital -Novartis AG -Pfizer Inc. -Sanofi -Sirtex Medical Limited -Stanford University -Sun Yat-sen University -The University of Texas M. D. Anderson Cancer Center For more information visit http://www.researchandmarkets.com/research/bt...ver_cancer About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Sirtex Medical Inc. Reports 21 Percent Dose Sales Growth of SIR-Spheres(R) microspheres
Business Wire - Tue Sep 03, 10:44AM CDT
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, recently announced dose sales of SIR-Spheres microspheres grew a solid 21 percent with more than 4,750 doses being supplied in the Americas region for the year ending June 30, 2013.

Sirtex Reports 13.1 per cent Dose Sales Growth in Fourth Quarter
Business Wire - Wed Jul 03, 3:42AM CDT
Sirtex Medical Limited (ASX:SRX) today announced dose sales of its SIR-Spheres(R) microspheres targeted radiation therapy for liver cancer grew 13.1 per cent for the quarter ended 30 June 2013 compared to the previous corresponding period. For Financial Year 2013 dose sales of SIR-Spheres microspheres grew 19 per cent. Despite being off a higher base, the FY2013 result delivers continued strong dose sales growth following the 23 per cent growth in FY2012, 19 per cent growth in FY2011 and 14 per cent growth in FY2010.

Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets
PR Newswire - Thu Jun 20, 5:00AM CDT
Sirtex Medical Limited (ASX: SRX) and US-based Surefire Medical today announced a sales and marketing partnership to distribute Surefire's range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.

CEO of Sirtex Medical Gilman Wong Selected for Inclusion in The CEO Magazine
PRWeb - Mon May 27, 6:11AM CDT
On a beautiful night in Sydney, the publication that you hold in your hands hosted the 2012 Executive of the Year Awards, recognising Australia's best C-suite leaders. The top accolade for the evening went to Gilman Wong, CEO of Sirtex Medical. Gilman received the award for his tireless work with the global workforce that has brought hope and relief to people with inoperable liver cancer.

Sirtex Completes Patient Recruitment for SIRFLOX Study Evaluating SIR-Spheres(R) Microspheres as First-Line Treatment for Colorectal Liver Metastases
Business Wire - Sat Apr 13, 7:00AM CDT
Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, announced yesterday the completion of patient recruitment into the group's landmark SIRFLOX randomized controlled trial of SIR-Spheres(R) microspheres for patients with metastatic colorectal cancer. The SIRFLOX study is the world's largest randomized controlled trial in interventional oncology with more than 500 patients enrolled.

Sirtex Medical Inc. Announces Half-Year Dose Sales Report
Business Wire - Mon Mar 04, 8:50AM CST
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, announced today that dose sales of SIR-Spheres(R) microspheres in the U.S. grew more than 35 percent for the first half of the company's fiscal year, compared to the same period last year. Globally the company reported dose sales growth of 30.5 percent in the six months ending Dec. 31, 2012.

Sirtex Medical Inc. Hosts Dinner Symposium at the 2013 American Hepato-Pancreato-Biliary Association's Annual Meeting
Business Wire - Tue Feb 19, 8:00AM CST
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, announced today it will host a dinner symposium during the 2013 American Hepato-Pancreato-Biliary Association's (AHPBA) Annual Meeting. The educational event will take place Thursday, Feb. 21 from 7-8:30 p.m.at the Eden Roc Renaissance in Miami.

Sirtex Medical: Interim report - half-year ended 31 December 2012
Business Wire - Thu Feb 14, 7:00AM CST
--Global dose sales growth of 30.5 per cent

Sirtex Medical Inc. Announces Second Quarter Sales Growth
Business Wire - Tue Jan 15, 8:00AM CST
Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, innovative liver cancer therapies, announced today that dose sales of SIR-Spheres(R) microspheres in the U.S. grew 29 percent for the second quarter of fiscal year 2013 over the same period last year. Globally the company reported dose sales grew 25 percent year-on-year for the second fiscal quarter of 2013 ending Dec. 31, 2012.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 13

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 148

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 221

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 199

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 53

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 83

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading

Top 5 Most Recently Viewed Articles

boberdoo Launches Dynamic Consent for Enhanced User Privacy

Updated Category News Views 92

boberdoo's Innovative Approach to One-to-One Consent boberdoo is making waves with its Dynamic Consent solution, a vital tool for businesses looking to comply with the FCC's one-to-one consent regulation. This live solution has been available since May 2024 and is designed to enhance transparency in lead generation by allowing consumers to have a voice in which companies...

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 254

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
Kyocera Unveils Exclusive Knife Set Celebrating 40 Years of Innovation

Updated Category News Views 62

Kyocera celebrated four decades of pushing boundaries in ceramic cutlery, revealing an exclusive two-piece knife set designed for both chefs and home cooks. The knives—a 4.5-inch Utility and a 5.5-inch Santoku—come dressed in vibrant Aegean Blue or Botanical Green and carry a price tag of $85. This limited-edition release is set to hit select retailers by late fall...

Continue Reading
PTC Plans Conference Call for Upcoming Fiscal Q1 Results

Updated Category News Views 145

PTC to Hold Fiscal Q1 Conference Call Boston, January 2026 — PTC (NASDAQ: PTC) is gearing up to unveil its financial performance for the first quarter of fiscal year 2026 on February 4. Investors and interested parties are invited to join a conference call and webcast at 5 PM Eastern Time, right after the stock market closes. This event will provide valuable insights...

Continue Reading
Moke America Unveils Enhanced Electric Street Vehicle for All

Updated Category News Views 282

Introducing the New Electric Street-Legal Moke Moke America, the beloved electric vehicle manufacturer, has taken a bold step forward with the launch of its latest street-legal Moke. Previously classified as a Low Speed Vehicle, this newly upgraded Moke can now reach an impressive top speed of 45 MPH, transforming the driving experience into something truly exhilarating....

Continue Reading